![What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper. - Abstract - Europe PMC What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5812308/bin/JOP.2017.026435ta2.jpg)
What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper. - Abstract - Europe PMC
![Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology](https://www.spandidos-publications.com/article_images/ol/18/5/ol-18-05-4947-g01.jpg)
Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology
![Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer - ScienceDirect Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1470204518303486-gr5.jpg)
Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer - ScienceDirect
![Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.20.02063/asset/images/large/jco.20.02063ta5.jpeg)
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology
![Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review - European Urology Focus Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/22b76ee9-8c64-42bc-919b-3981359a1324/gr1_lrg.jpg)
Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review - European Urology Focus
![Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.20.02063/asset/images/large/jco.20.02063t3.jpeg)
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology
![The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients—Part I: Early-Stage Disease | Drugs & Aging The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients—Part I: Early-Stage Disease | Drugs & Aging](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40266-020-00748-z/MediaObjects/40266_2020_748_Fig2_HTML.png)
The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients—Part I: Early-Stage Disease | Drugs & Aging
![Cureus | Use of a Chemotherapy Toxicity Prediction Tool to Decrease Risks for Hospitalization in Older Patients | Article Cureus | Use of a Chemotherapy Toxicity Prediction Tool to Decrease Risks for Hospitalization in Older Patients | Article](https://assets.cureus.com/uploads/figure/file/357718/article_river_f2ae0550b5e211ec914f6b0bf66419df-Figure-1.png)
Cureus | Use of a Chemotherapy Toxicity Prediction Tool to Decrease Risks for Hospitalization in Older Patients | Article
![Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.20.02063/asset/images/large/jco.20.02063t4.jpeg)
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology
![ASCO GUIDELINES Bundle - Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy ASCO GUIDELINES Bundle - Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy](https://content.cdntwrk.com/files/aT0xNDc1NDQ0JnA9OCZ2PTEmY21kPXYmc2lnPTlkOWZmZWJhYTQ2YWUxNzg3MzcyMTEyY2ZiYzUwZTA3/-w-450-80.jpg)